Chembio

CEMI NASDAQ
5.82
+0.10
+1.75%
Opening 14:09 07/15 EDT
Open
5.67
Prev Close
5.72
High
5.82
Low
5.60
Volume
6.91K
Avg Vol (3M)
37.18K
52 Week High
11.55
52 Week Low
4.850
% Turnover
0.04%
Market Cap
99.91M
1D
5D
1M
3M
1Y
5Y

Related

Webull offers Chembio CEMI stock price, real time market quotes, professional analyst ratings, and in-depth charts, You can share investing ideas in community to communicate with others and learn trading skills.

Company Profile

Chembio Diagnostics, Inc. (Chembio), and its subsidiary, Chembio Diagnostic Systems, Inc., develop, manufacture, market and license rapid point-of-care diagnostic tests (POCTs) that detect infectious diseases. The Company's products available are rapid tests for the detection of human immunodeficiency virus (HIV) 1/2 antibodies, and a multiplex rapid test for the detection of HIV and Syphilis antibodies. The HIV 1/2 rapid tests employ in-licensed and lateral flow technologies that are used with all blood matrices as samples, and are manufactured in a standard cassette format, a dipstick format and a barrel format. Its HIV 1/2 rapid antibody detection test incorporates the Dual Path Platform (DPP) POCT technology. The DPP HIV 1/2 Assay detects antibodies to HIV 1 and 2 in oral fluid samples, as well as in all blood matrices. The Company's product pipeline includes a multiplex rapid test for earlier detection of HIV and a multiplex test that detects HIV and Syphilis specific antibodies.
MORE >

Recently

Name
Price
%Change